Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

How Would a New BRICS Currency Affect the US Dollar? (Updated 2025)

13 Canadian Crypto ETFs (Updated 2025)

10 Top Oil-producing Countries

Could the Silver Price Really Hit $100 per Ounce?

Mali Enforces Gold Seizure at Barrick's Loulo-Gounkoto Mine

Uranium Stocks: 5 Biggest Companies

A State-by-State Guide to Cannabis in Australia

How Could Trump's US Election Win Affect the Gold Price?

Can You Invest in Elon Musk’s Neuralink?

Trending Press Releases

European Lithium Limited (ASX: EUR) – Trading Halt

Flynn Expands Key Gold Targets at Golden Ridge, NE Tasmania

Skyharbour to Carry Out Multi-Phased, 2025 Drilling Campaign Totalling 16-18,000 Metres at its Russell Lake and Moore Uranium Projects, Saskatchewan

Boab Metals: Advancing Toward Near-Term Lead, Silver Production in Western Australia

Spearmint More Than Doubles its Crypto Exposure

More Press Releases
Trending Companies

Skyharbour Resources

SYH:CA

Rua Gold

RUA:CC

First Helium

HELI:CA

Freegold Ventures

FVL:CA
More Companies
Trending Reports

2025 Lithium Market Outlook

2025 Copper Outlook Report

2025 Oil & Gas Outlook Report

2025 Uranium Outlook

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold Price
Silver Price
Copper Price
Oil Price
Uranium
Artificial Intelligence
loader

Delcath Systems

NASDAQ:DCTH

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers.

Press Releases
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

Interactive Chart

×